BioFrontier Partners
Tokyo-based venture capital firm focused on investment in private bio- and healthcare-related companies and providing life-science consulting and research services. The firm operates multiple investment partnerships (funds) targeting domestic and international bio/healthcare companies and offers post-investment technical guidance through selected external advisors. It also maintains affiliated companies active in agricultural biotechnology and fund administration.
Industries
Nr. of Employees
small (1-50)
BioFrontier Partners
Kitano Building 3rd FL, 2-6-11 Nihonbashi-kayabacho, Chuo-ku, Tokyo 103-0025, Japan
Portfolio
Engages in application development, product planning and commercialization of biofunctional substances for pharmaceuticals, agrochemicals, cosmetics and health foods; provides end-to-end support from product concept to manufacturing and regulatory response.
#Agricultural/biological products, functional biological substances, cosmetics & health-food raw materials
Originally established as a public-private venture focused on rice genome resources and genome breeding; developed multiple new rice varieties using genome-assisted breeding to shorten development time from ~10 years to 2–3 years. Became 100% subsidiary of BioFrontier Partners in 2014.
#Agricultural biotechnology, plant genomics
Provides administrative services for investment partnerships from formation through liquidation and offers accounting/administrative support to operating companies and ventures.
#Fund administration and accounting services
Engages in application development, product planning and commercialization of biofunctional substances for pharmaceuticals, agrochemicals, cosmetics and health foods; provides end-to-end support from product concept to manufacturing and regulatory response.
#Agricultural/biological products, functional biological substances, cosmetics & health-food raw materials
Originally established as a public-private venture focused on rice genome resources and genome breeding; developed multiple new rice varieties using genome-assisted breeding to shorten development time from ~10 years to 2–3 years. Became 100% subsidiary of BioFrontier Partners in 2014.
#Agricultural biotechnology, plant genomics
Provides administrative services for investment partnerships from formation through liquidation and offers accounting/administrative support to operating companies and ventures.
#Fund administration and accounting services